{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:59:29Z","timestamp":1790693969580,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejca.2017.09.022","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T18:45:29Z","timestamp":1508438729000},"page":"266-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability\/DNA mismatch repair deficiency"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-5162","authenticated-orcid":false,"given":"R.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Buhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bardier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-B.","family":"Bachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Gornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lopez-Trabada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bertheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Parc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vernerey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Svrcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-7095","authenticated-orcid":false,"given":"Thierry","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.09.022_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bulcan.2016.11.006","article-title":"Immunotherapy and patients treated for cancer with microsatellite instability","volume":"104","author":"Colle","year":"2017","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.ejca.2017.09.022_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2016.211","article-title":"A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome","author":"Adar","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2017.09.022_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jmedgenet-2014-102552","article-title":"Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)","volume":"51","author":"Newton","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejca.2017.09.022_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jmedgenet-2011-100714","article-title":"Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification","volume":"49","author":"Parsons","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejca.2017.09.022_bib5","first-page":"3455","article-title":"Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability","volume":"58","author":"Cunningham","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2017.09.022_bib6","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib7","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study","volume":"33","author":"Andr\u00e9","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib8","doi-asserted-by":"crossref","first-page":"djv438","DOI":"10.1093\/jnci\/djv438","article-title":"Efficacy of adjuvant chemotherapy in colon cancer with microsatellite instability: a large multicenter AGEO study","volume":"108","author":"Tougeron","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.09.022_bib9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnci\/djr153","article-title":"DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy","volume":"103","author":"Sinicrope","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.09.022_bib10","first-page":"1773","article-title":"Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy","volume":"23","author":"Brueckl","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2017.09.022_bib11","first-page":"2715","article-title":"Microsatellite instability and sensitivity to FOLFOX treatment in metastatic colorectal cancer","volume":"27","author":"Des Guetz","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2017.09.022_bib12","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal\u00a0cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.09.022_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","article-title":"Deficient mismatch repair system in patients with sporadic advanced colorectal cancer","volume":"100","author":"Koopman","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2017.09.022_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21873\/anticanres.11313","article-title":"Metastatic pattern of stage IV colorectal cancer with high-frequency microsatellite instability as a prognostic factor","volume":"37","author":"Fujiyoshi","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2017.09.022_bib15","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","article-title":"Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies","volume":"20","author":"Venderbosch","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2017.09.022_bib16","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2017.09.022_bib17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer","volume":"147","author":"Giardiello","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2017.09.022_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","article-title":"Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk\u2013colorectal cancer: European Society for Medical Oncology clinical practice guidelines","volume":"33","author":"Stoffel","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib20","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-07-1489","article-title":"Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer","volume":"14","author":"French","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2017.09.022_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2015.5225","article-title":"Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab: a post hoc analysis of the PETACC-8 trial","volume":"2","author":"Taieb","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdu100","article-title":"Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)","volume":"25","author":"Goldstein","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial","volume":"28","author":"Roth","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2011.39.5814","article-title":"Identification of a poor-prognosis BRAF-mutant\u2013like population of patients with colon cancer","volume":"30","author":"Popovici","year":"2012","journal-title":"J Clin\u00a0Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib25","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2017.09.022_bib26","doi-asserted-by":"crossref","first-page":"vi73","DOI":"10.1093\/annonc\/mdt209","article-title":"Familial risk-colorectal cancer: ESMO clinical practice guidelines","volume":"24","author":"Balma\u00f1a","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.09.022_bib27","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2016.34.4_suppl.195","article-title":"Programmed death-1 blockade in mismatch repair deficient colorectal cancer","volume":"34","author":"Le","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917313035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917313035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T14:57:54Z","timestamp":1535295474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917313035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":27,"alternative-id":["S0959804917313035"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.09.022","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability\/DNA mismatch repair deficiency","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}